Relative Survival of Long-Term Hematopoietic Cell Transplant Recipients Approaches General Population Rates

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 10, 2009, Pages 1323-1330

  Nivison Smith, Ian ^a   Simpson, Judy M ^b   Dodds, Anthony J ^c   Ma, David D F ^c   Szer, Jeff ^d   Bradstock, Kenneth F ^e  

^a ABMTRR   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

Hematopoietic cell transplant; Long term; Relative survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUSTRALIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEW ZEALAND; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 69749088992     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.06.014     Document Type: Article

References (35)

1. Urbano-Ispizua A., Schmitz N., de Witte T., et al. Allogeneic and autologous transplantation for haematologic diseases, solid tumors and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 29 (2002) 639-646
2. Laudi N., Arora M., Burns L.J., et al. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma. Biol Blood Marrow Transplant 11 (2005) 129-135
3. Majhail N.S., Weisdorf D.J., Defor T.E., et al. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biol Blood Marrow Transplant 12 (2006) 1065-1072
4. Mollee P., Gupta V., Song K., et al. Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplant 33 (2004) 1201-1208
5. Bhatia S., Francisco L., Carter A., et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110 (2007) 3784-3792
6. Badell I., Muñoz A., Ortega J.J., et al. Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998. Bone Marrow Transplant 35 (2005) 895-901
7. Greinix H.T., Nachbaur D., Krieger O., et al. Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry. Br J Haematol 117 (2002) 914-923
8. Baker K.S., DeFor T.E., Burns L.J., Ramsay N.K.C., Neglia J.P., and Robison L.L. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 21 (2003) 1352-1358
9. Bhatia S., Louie A.D., Bhatia R., et al. Solid cancers after bone marrow transplantation. J Clin Oncol 19 (2001) 464-471
10. Curtis R.E., Rowlings P.A., Deeg H.J., et al. Solid cancers after bone marrow transplantation. N Engl J Med 336 (1997) 897-904
11. Socié G., Curtis R.E., Deeg H.J., et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 18 (2000) 348-357
12. Hows J.M., Passweg J.R., Tichelli A., et al. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. Bone Marrow Transplant 38 (2006) 799-805
13. Mughal T.I., Yong A., Szydlo R.M., et al. Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol 115 (2001) 569-574
14. Patriarca F., Skert C., Bonifazi F., et al. Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation. Haematologica 91 (2006) 1268-1272
15. Rizzo J.D., Wingard J.R., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 12 (2006) 138-151
16. Socié G., Veum Stone J., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med 341 (1999) 14-21
17. Bhatia S., Robison L.L., Francisco L., et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105 (2005) 4215-4222
18. Pond G.R., Lipton J.H., and Messner H.A. Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population. Biol Blood Marrow Transplant 12 (2006) 422-429
19. Syrjala K.L., Langer S.L., Abrams J.R., Storer B.E., and Martin P.J. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 23 (2005) 6596-6606
20. Nivison-Smith I., Bradstock K.F., Dodds A.J., et al. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004. Biol Blood Marrow Transplant 13 (2007) 905-912
21. Dickman P.W., and Adami H.O. Interpreting trends in cancer patient survival. J Int Med 260 (2006) 103-117
22. Lambert P.C., Thompson J.R., Weston C.L., and Dickman P.W. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 8 (2007) 576-594
23. Dickman P.W., Sloggett A., Hills M., and Hakulinen T. Regression models for relative survival. Stat Med 23 (2004) 51-64
24. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany), 2007, www.mortality.org.
25. Australian Bureau of Statistics. Life Tables, Australia 3302.0.55.001. ABS, 2007, www.abs.gov.
26. Statistics New Zealand. New Zealand Life Tables 2000-2002. Staistics New Zealand 2006, www.stats.govt.nz.
27. Kennedy G.A., Butler J., Morton J., et al. Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow-up of a single center experience. Clin Lab Haematol 28 (2006) 189-197
28. Kristinsson Y.K., Landgren O., Dickman P.W., Derolf A.R., and Björkholm M. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol 25 (2007) 1993-1999
29. Ringdén O., Horowitz M.M., Gale R.P., et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 270 (1993) 57-60
30. Ringdén O., Remberger M., Mattsson J., et al. Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age. Bone Marrow Transplant 21 (1998) 43-49
31. Rapoport A.P., DiPersio J.F., Martin B.A., et al. Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years. Bone Marrow Transplant 15 (1995) 523-530
32. Kusnierz-Glaz C.R., Schlegel P.G., Wong R.M., et al. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. J Clin Oncol 15 (1997) 18-25
33. Schmitz N., Eapen M., Horowitz M.M., et al. Long-term outcomes of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 108 (2006) 4288-4290
34. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 13 (2007) 1461-1468
35. Schrezenmeier H., Passweg J.R., Marsh J.C.W., et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 110 (2007) 1397-1400